Biomarkers and Therapeutic Targets in Insulin Resistance
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 136
Special Issue Editor
Special Issue Information
Dear Colleagues,
Insulin resistance plays a major role in the pathogenesis of metabolic diseases, including type 2 diabetes, obesity, and cardiovascular disease. Understanding the underlying molecular mechanisms and identification of novel biomarkers and therapeutic targets are critical for early diagnosis and treatment. This Special Issue, entitled "Biomarkers and Therapeutic Targets in Insulin Resistance", will offer a platform to discuss the current progress in this area, with an emphasis on molecular, genetic, and biochemical markers for the prediction and monitoring of insulin resistance. Novel therapeutic approaches, including pharmacologic agents, lifestyle changes, and personalized medicine treatment, to manage insulin resistance and its complications will also be featured. This special seeks to provide a comprehensive overview of the state of knowledge and avenues for future research in this rapidly evolving area.
Dr. Mohamed Elrayess
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- insulin resistance
- biomarkers
- therapeutic targets
- type 2 diabetes
- metabolic syndrome
- obesity
- molecular mechanisms
- pharmacologic treatments
- precision medicine
- cardiovascular diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
